Rena G. Lapidus

6.4k total citations · 2 hit papers
99 papers, 4.9k citations indexed

About

Rena G. Lapidus is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Rena G. Lapidus has authored 99 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Biology, 34 papers in Oncology and 22 papers in Hematology. Recurrent topics in Rena G. Lapidus's work include Acute Myeloid Leukemia Research (21 papers), Cancer therapeutics and mechanisms (10 papers) and Epigenetics and DNA Methylation (9 papers). Rena G. Lapidus is often cited by papers focused on Acute Myeloid Leukemia Research (21 papers), Cancer therapeutics and mechanisms (10 papers) and Epigenetics and DNA Methylation (9 papers). Rena G. Lapidus collaborates with scholars based in United States, Japan and Italy. Rena G. Lapidus's co-authors include Nancy E. Davidson, Stephen B. Baylin, James G. Herman, Jean‐Pierre J. Issa, Adrian Merlo, Li Mao, David Sidransky, Patricia M. Sokolove, Anne Ferguson and Sharyl J. Nass and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Rena G. Lapidus

97 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.

1995 1.2k citations Rena G. Lapidus, Jean‐Pierre J. Issa et al. PubMed profile →
E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.

1995 668 citations Rena G. Lapidus, Nancy E. Davidson et al. PubMed profile →

Peers

Countries citing papers authored by Rena G. Lapidus

Since Specialization

Citations

This map shows the geographic impact of Rena G. Lapidus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rena G. Lapidus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rena G. Lapidus more than expected).

Fields of papers citing papers by Rena G. Lapidus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rena G. Lapidus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rena G. Lapidus. The network helps show where Rena G. Lapidus may publish in the future.

Co-authorship network of co-authors of Rena G. Lapidus

This figure shows the co-authorship network connecting the top 25 collaborators of Rena G. Lapidus. A scholar is included among the top collaborators of Rena G. Lapidus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rena G. Lapidus. Rena G. Lapidus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dual targeting of glutamine and serine metabolism in acute myeloid leukemia 2024 ·Frontiers in Oncology ·(unknown), Dominique Bollino, Amol C. Shetty, Brandon Carter‐Cooper, Rena G. Lapidus, Ashkan Emadi	3
2	Selective targeting of metastatic ovarian cancer using an engineered anthrax prodrug activated by membrane-anchored serine proteases 2022 ·Proceedings of the National Academy of Sciences ·Nadire Duru, Nisha R. Pawar, Erik W. Martin, Marguerite S. Buzza, (unknown), Rena G. Lapidus, Shihui Liu, Jocelyn Reader, Gautam G. Rao, Dana M. Roque, Stephen H. Leppla, Toni Antalis	8
3	Simultaneously targeting ErbB family kinases and PI3K in HPV-positive head and neck squamous cell carcinoma 2022 ·Oral Oncology ·Zejia Yang, Jipei Liao, Lisa M. Schumaker, Brandon Carter‐Cooper, Rena G. Lapidus, Xiaoxuan Fan, Daria A. Gaykalova, Ranee Mehra, Kevin J. Cullen, Hancai Dan	8
4	Translatome changes in acute myeloid leukemia cells post exposure to pegcrisantaspase and venetoclax 2022 ·Experimental Hematology ·Bandish Kapadia, Amol C. Shetty, Dominique Bollino, Binny Bhandary, Rena G. Lapidus, (unknown), Anup Mahurkar, Ronald B. Gartenhaus, Richard L. Eckert, Ashkan Emadi	6
5	PP2A-activating Drugs Enhance FLT3 Inhibitor Efficacy through AKT Inhibition–Dependent GSK-3β–Mediated c-Myc and Pim-1 Proteasomal Degradation 2021 ·Molecular Cancer Therapeutics ·(unknown), (unknown), Christopher M. Bailey, (unknown), (unknown), Rena G. Lapidus, Sandrine Niyongere, Jaya Sangodkar, Yin Wang, Danilo Perrotti, Goutham Narla, Maria R. Baer	17
6	Deep dissection of the antiviral immune profile of patients with COVID-19 2021 ·Communications Biology ·Djordje Atanackovic, (unknown), Forat Lutfi, Diego de Miguel‐Pérez, Xiaoxuan Fan, (unknown), Erica R. Vander Mause, (unknown), John W. Baddley, Heather D. Mannuel, (unknown), Kim G. Hankey, Rena G. Lapidus, Michael Kleinberg, Joseph Rabin, Carl Shanholtz, Christian Rolfo, Aaron P. Rapoport, Saurabh Dahiya, Tim Luetkens	6
7	Eight-Day Point of Care CAR T-Cell Manufacturing on Clinimacs Prodigy from Healthy Donors As a Proof-of-Concept Study 2021 ·Blood ·Kim G. Hankey, Tim Luetkens, (unknown), John C. McLenithan, John M. Braxton, (unknown), (unknown), Rena G. Lapidus, (unknown), (unknown), Jean A. Yared, Nancy M. Hardy, Ulrike Mock, (unknown), (unknown), Xiaoxuan Fan, Djordje Atanackovic, Aaron P. Rapoport, Saurabh Dahiya	1
8	Venetoclax and pegcrisantaspase for complex karyotype acute myeloid leukemia 2020 ·Leukemia ·Ashkan Emadi, Bandish Kapadia, Dominique Bollino, Binny Bhandary, Maria R. Baer, Sandrine Niyongere, Erin T. Strovel, (unknown), Elizabeth Chang, Eun Yong Choi, Xinrong Ma, (unknown), Brandon Carter‐Cooper, (unknown), Curt I. Civin, Anup Mahurkar, Amol C. Shetty, Ronald B. Gartenhaus, Farin Kamangar, Rena G. Lapidus	23
9	Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer 2018 ·British Journal of Cancer ·Zhipeng Li, Jipei Liao, Zejia Yang, Eun Yong Choi, Rena G. Lapidus, Xuefeng Liu, Kevin J. Cullen, Hancai Dan	13
10	Concurrent Inhibition of Pim and FLT3 Kinases Enhances Apoptosis of FLT3-ITD Acute Myeloid Leukemia Cells through Increased Mcl-1 Proteasomal Degradation 2017 ·Clinical Cancer Research ·(unknown), Karthika Natarajan, (unknown), (unknown), Rena G. Lapidus, (unknown), (unknown), Rossana Trotta, Eduardo Dávila, Manfred Kraus, Dennis Huszar, Adriana E. Tron, Danilo Perrotti, Maria R. Baer	36
11	Targeting IκB Kinase β/NF-κB Signaling in Human Prostate Cancer by a Novel IκB Kinase β Inhibitor CmpdA 2016 ·Molecular Cancer Therapeutics ·Yanting Zhang, Rena G. Lapidus, Peiyan Liu, Eun Yong Choi, (unknown), Arif Hussain, Xinghuan Wang, Xuefeng Liu, Han C. Dan	32
12	Synthesis, anticancer activity, and SAR analyses of compounds containing the 5:7-fused 4,6,8-triaminoimidazo[4,5-e][1,3]diazepine ring system 2016 ·Bioorganic & Medicinal Chemistry ·Min Xie, Rena G. Lapidus, Mariola Sadowska, Martin J. Edelman, Ramachandra S. Hosmane	16
13	Translational Phase I Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytarabine and Etoposide in Patients with Relapsed, Refractory, or High-Risk Acute Myeloid Leukemia 2013 ·Clinical Cancer Research ·Ivana Gojo, Ming Tan, Hong‐Bin Fang, Mariola Sadowska, Rena G. Lapidus, Maria R. Baer, France Carrier, Jan H. Beumer, (unknown), Rahul Srivastava, Igor Espinoza‐Delgado, Douglas D. Ross	40
14	Comparison of Neuropathy-Inducing Effects of Eribulin Mesylate, Paclitaxel, and Ixabepilone in Mice 2011 ·Cancer Research ·Krystyna M. Wozniak, K. Nomoto, Rena G. Lapidus, Ying Wu, Valentina Carozzi, Guido Cavaletti, Kazuhiro Hayakawa, Satoru Hosokawa, Murray J. Towle, Bruce A. Littlefield, Barbara S. Slusher	75
15	Glutamate Carboxypeptidase Inhibition Reduces the Severity of Chemotherapy-Induced Peripheral Neurotoxicity in Rat 2009 ·Neurotoxicity Research ·Valentina Carozzi, A Chiorazzi, A Canta, Rena G. Lapidus, Barbara S. Slusher, Krystyna M. Wozniak, Guido Cavaletti	57
16	Prostate-specific membrane antigen (PSMA) enzyme activity is elevated in prostate cancer cells 2000 ·The Prostate ·Rena G. Lapidus, Carol W. Tiffany, John T. Isaacs, Barbara S. Slusher	107
17	Characterization of the enzymatic activity of PSM: Comparison with brain NAALADase 1999 ·The Prostate ·Carol W. Tiffany, Rena G. Lapidus, (unknown), David C. Calvin, Barbara S. Slusher	75
18	The regulation of estrogen receptor expression and function in human breast cancer 1998 ·Cancer treatment and research ·Anne Ferguson, Rena G. Lapidus, Nancy E. Davidson	9
19	Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors. 1996 ·PubMed ·Rena G. Lapidus, Anne Ferguson, Yvonne Ottaviano, Fritz F. Parl, Helene S. Smith, Sigmund A. Weitzman, Stephen B. Baylin, Jean‐Pierre J. Issa, Nancy E. Davidson	203
20	Use of Carboxyatractylate and Tight-Binding Inhibitor Theory to Determine the Concentration of Functional Mitochondrial Adenine Nucleotide Translocators in a Reconstituted System 1993 ·Analytical Biochemistry ·(unknown), Rena G. Lapidus, Patricia M. Sokolove	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact